Article info
PDFViewpoint
Vulnerability of the medical product supply chain: the wake-up call of COVID-19
- Correspondence to Dr Fiona A Miller, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; fiona.miller{at}utoronto.ca
Citation
Vulnerability of the medical product supply chain: the wake-up call of COVID-19
Publication history
- Received August 2, 2020
- Revised October 17, 2020
- Accepted October 22, 2020
- First published November 2, 2020.
Online issue publication
March 18, 2021
Article Versions
- Previous version (18 March 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage